Daniel Grosslight

Stock Analyst at Citigroup

(1.07)
# 3,834
Out of 5,055 analysts
110
Total ratings
31.82%
Success rate
-14.64%
Average return

Stocks Rated by Daniel Grosslight

Health Catalyst
Nov 11, 2025
Maintains: Neutral
Price Target: $3.5$3.25
Current: $2.24
Upside: +45.09%
Claritev
Nov 10, 2025
Maintains: Buy
Price Target: $74$80
Current: $38.13
Upside: +109.81%
Cardinal Health
Oct 31, 2025
Maintains: Neutral
Price Target: $165$190
Current: $206.18
Upside: -7.85%
Waystar Holding
Oct 31, 2025
Maintains: Buy
Price Target: $47$49
Current: $34.29
Upside: +42.90%
Teladoc Health
Oct 21, 2025
Maintains: Neutral
Price Target: $9.5$11
Current: $6.75
Upside: +55.56%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820$860
Current: $855.23
Upside: +0.56%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11$7
Current: $2.89
Upside: +142.21%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3$1
Current: $0.54
Upside: +86.22%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25$30
Current: $35.58
Upside: -15.68%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21$18
Current: $3.87
Upside: +365.12%
Maintains: Buy
Price Target: $7$6.25
Current: $2.85
Upside: +119.30%
Maintains: Buy
Price Target: $31$35
Current: $20.60
Upside: +69.90%
Initiates: Buy
Price Target: $25
Current: $23.22
Upside: +7.67%
Maintains: Neutral
Price Target: $9$10
Current: $3.77
Upside: +165.25%
Downgrades: Sell
Price Target: $7$8
Current: $11.99
Upside: -33.28%
Maintains: Neutral
Price Target: $1.5$1.25
Current: $1.46
Upside: -14.38%
Downgrades: Neutral
Price Target: $7$3.5
Current: $3.18
Upside: +10.06%
Initiates: Outperform
Price Target: $13
Current: $9.33
Upside: +39.34%